Campbell Jonathon R, Russell W Alton, Wagner Caroline E, Manuel Douglas G, Anipindi Varun, Baral Prativa, Evans Timothy G, Hankins Catherine A, Sander Beate
Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Department of Medicine, McGill University, Montreal, QC, Canada.
Can J Public Health. 2025 Jun 30. doi: 10.17269/s41997-025-01075-9.
The Government of Canada, through the COVID-19 Immunity Task Force (CITF), supported over 100 serosurveillance studies during the COVID-19 pandemic, building and strengthening the technical infrastructure necessary for a national serosurveillance network. The value of such a network extends beyond infectious disease surveillance to monitoring non-communicable diseases and chemical and environmental contaminants, advancing immunology and medicine, and contributing to national and international research and training. A serosurveillance network can contribute to skill development and retention of the health workforce and provide a platform to rapidly evaluate diagnostics for emerging pathogens. Although full linkage of health data across jurisdictions remains a challenge for such a serosurveillance network to realize its full potential, there are several value streams that make it a worthwhile goal to pursue: improving population health, supporting policy decisions, and facilitating research and diagnostic development. In the aftermath of the COVID-19 pandemic, an integrated pan-Canadian serosurveillance network is a crucial asset going forward.
加拿大政府通过新冠免疫特别工作组（CITF），在新冠疫情期间支持了100多项血清学监测研究，构建并强化了国家血清学监测网络所需的技术基础设施。这样一个网络的价值不仅限于传染病监测，还包括监测非传染性疾病以及化学和环境污染物、推动免疫学和医学发展，以及为国家和国际研究与培训做出贡献。血清学监测网络有助于卫生人力的技能培养和留存，并提供一个平台来快速评估针对新兴病原体的诊断方法。尽管跨辖区的健康数据全面关联对于这样一个血清学监测网络充分发挥其潜力而言仍是一项挑战，但有几个价值流使其成为一个值得追求的目标：改善人群健康、支持政策决策以及促进研究和诊断方法的开发。在新冠疫情之后，一个整合的泛加拿大血清学监测网络是未来的一项关键资产。
